From November 1, 2022 to November 2, 2022, the company has repurchased 1,150,602 shares, representing 1.49% for ¥9,991.92 million. With this, the company has completed the repurchase of 1,150,602 shares, representing 1.49% for ¥9,991.92 million under the buyback announced on November 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,380 JPY | -0.74% | -2.94% | -20.77% |
31/03 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
30/03 | Kobayashi factory searched over deaths possibly linked to supplements | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.77% | 2.61B | |
+12.23% | 388B | |
+10.21% | 132B | |
+16.52% | 76.2B | |
-16.82% | 62.43B | |
-9.10% | 47.67B | |
-10.82% | 36.76B | |
+5.49% | 34.51B | |
+10.61% | 15.35B | |
-4.57% | 11.3B |
- Stock Market
- Equities
- 4967 Stock
- News Kobayashi Pharmaceutical Co., Ltd.
- Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 1, 2022.